S&P 500
1969.95
-8.96 -0.45%
Dow Indu
16912.11
-70.48 -0.42%
Nasdaq
4444.48
-0.43 -0.01%
Crude Oil
101.42
+0.45 +0.45%
Gold
1299.645
+0.440 +0.03%
Euro
1.34018
-0.00122 -0.09%
US Dollar
81.393
+0.183 +0.24%
Weak

NASDAQ 100 INDEX (E-MINI) Sep 2014 (E) Future

Chicago Mercantile ExchangeNASDAQ 100 INDEX (E-MINI) Sep 2014 (E) (CME:NQ.U14.E)

3974.25 +22.00 (+0.56%)

2014-07-30 08:52:35, 10 min delay

NASDAQ 100 INDEX (E-MINI) Sep 2014 (E) (CME:NQ.U14.E) Future Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price3974.25
Settle Time16:21
Previous Close3956.75
Low3956.00
Open Int.373000
Contract High3991.25
Contract Low3133
Estimated Volume16647
Open Time18:00
Net Change22.00
Open3957.25
High3978.75
Volume28,306
Time2014-07-30 08:52:35
Contract High Date2014-07-24
Contract Low Date2013-10-08
Expiration2014-09-19
Close Time17:15

Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.

First Name
Last Name
Email
 
By filling out the form, you'll receive instant access to Today's Top 50 Trending Stocks list and other trading resources from INO.com.

List of Top Stocks


Trader's Blog

Time To Buy Tesla
   21 hours ago
Next Gold Buying Opportunity May Be Just Around the Corner
   23 hours ago
The Truth About Amazon
   1 day ago

Today's Financial News

Strong demand for hepatitis C drug despite an outcry over its $1,000-per-pill cost

14 hours ago

WASHINGTON (AP) — The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million. But clinical and commercial successes are also triggering scrutiny for the drug's manufacturer, California-based Gilead Sciences Inc., which just reported second-quarter profits of $3.66 billion, or a net margin of 56 percent.

Panera second-quarter profit falls 3.6 percent, misses forecast

14 hours ago

ST. LOUIS (AP) — Panera Bread Co. (PNRA) on Tuesday reported earnings that decreased by 3.6 percent in its second quarter, and missed analysts' expectations. Earnings, adjusted for non-recurring gains, were $1.74 per share. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.75 per share.

US, European Union order tough new economic, energy, defense sanctions on Russia over Ukraine

14 hours ago

WASHINGTON (AP) — Spurred to action by the downing of the Malaysian airliner, the European Union approved dramatically tougher economic sanctions Tuesday against Russia, including an arms embargo and restrictions on state-owned banks. President Barack Obama swiftly followed with an expansion of U.S. penalties targeting key sectors of the Russian economy.

Dreamworks reports 2Q loss following a profitable quarter a year ago

14 hours ago

GLENDALE, Calif. (AP) — Dreamworks Animation SKG Inc. (DWA) on Tuesday reported a second-quarter loss after posting a profit in the same period a year earlier. The company's results fell short of analysts' expectations. Losses, adjusted for non-recurring gains, came to 27 cents per share. The average estimate of analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.